INV-101 (Innovo Therapeutics)

N/A

Report date: 2025/05/22 11:37:46
NMEFirst In Class

Base Information

Drug NameINV-101 (Innovo Therapeutics)
Drug Alias NameINV-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen phosphorylase inhibitors
TargetsGlycogen phosphorylase
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInnovo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesInnovo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A